The world’s leading vaccine producer Serum Institute of India (SII) on Thursday claimed that the corona vaccine developed in collaboration with Oxford University and the AstraZeneca company is completely safe and effective. The company also claimed that the vaccine is being tested in India as per the standards.
SII appealed to the people to be patient and said that the vaccine is 60-70 percent effective even in the worst performance. People have started to question the initial results of the errors in the production of this experimental corona vaccine.
AstraZeneca and Oxford had previously claimed that the vaccine developed by them was very effective. But the company did not explain why some participants were not given the highest dose of the vaccine in the first dose as previously proposed.
In fact, the Oxford vaccine was found to be 90 percent effective in half the dose. While 62 per cent was effective on giving full doses. However, the scientific community has also raised questions on which the answers remain unanswered. But AstraZeneca has made public the omission behind this unique result. The Nature Journal quoted AstraZeneca vice president (biopharmaceutical-research and development) Mene Penalos as saying that the good results are the result of a mistake. When the vaccine trials began in late April, it was found that headaches, fatigue, and hand pain complaints were less than expected for those who had been vaccinated. Scientists could not understand the reason for this. Therefore, the data of the tests were checked from the beginning.
PM Modi will visit SII
At the same time, Prime Minister Narendra Modi will visit the Serum Institute of India (SII) in Pune on Saturday. A senior official gave this information on Thursday. SII has partnered with global pharmaceutical manufacturer AstraZeneca and Oxford University for the Kovid-19 vaccine. “We have received confirmation of Prime Minister Modi’s visit to Serum Institute of India on Saturday, but a detailed description of his program (minute-by-minute program) has not yet been received,” said Mandalayat Saurabh Rao of Pune. Had said on Tuesday that the Prime Minister was expected to visit Pune, and if that would happen, the aim would be to review the mechanism of corona virus infection vaccine manufacture, production and distribution mechanisms.